Zimmer Biomet Holdings's book value per share for the quarter that ended in Mar. 2026 was CHF51.59.
During the past 12 months, Zimmer Biomet Holdings's average Book Value Per Share Growth Rate was 4.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 4.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 1.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 2.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Zimmer Biomet Holdings was 240.70% per year. The lowest was -1.50% per year. And the median was 7.90% per year.
During the past 13 years, the highest P/B Ratio of Zimmer Biomet Holdings was 2.89. The lowest was 1.26. And the median was 2.05.
Good Sign:
Zimmer Biomet Holdings Inc stock PB Ratio (=1.39) is close to 10-year low of 1.26.
Zimmer Biomet Holdings (XSWX:ZBH) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Zimmer Biomet Holdings Book Value per Share Related Terms
Zimmer Biomet Holdings Book Value per Share Historical Data
* Premium members only.
The historical data trend for Zimmer Biomet Holdings's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:ZBH vs STE, PEN, GMED: Book Value per Share Comparison
For the Medical Devices subindustry, Zimmer Biomet Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zimmer Biomet Holdings PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where Zimmer Biomet Holdings's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Book Value per Share of CHF51.59 mean?
Zimmer Biomet Holdings (XSWX:ZBH) has a Book Value per Share of CHF51.59 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Zimmer Biomet Holdings and its competitors.
Is Zimmer Biomet Holdings' Book Value per Share too high?
Zimmer Biomet Holdings' current Book Value per Share is CHF51.59. Overall, Zimmer Biomet Holdings has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' Book Value per Share compare to STE and PEN?
Zimmer Biomet Holdings' Book Value per Share of CHF51.59 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Medical Devices & Instruments company?
A good Book Value per Share depends on the Medical Devices & Instruments industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Zimmer Biomet Holdings and its competitors. Zimmer Biomet Holdings's current Book Value per Share is CHF51.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Zimmer Biomet Holdings (XSWX:ZBH) has a current Book Value per Share of CHF51.59. The stock's GF Value™ is CHF101.61, compared to a current price of CHF73.50 — trading 27.7% below its estimated fair value. The current Book Value per Share is CHF51.59. Zimmer Biomet Holdings' overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current Book Value per Share is CHF51.59 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?
Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued.
The current stock price of CHF73.50 is trading 27.7% below its estimated GF Value™ of CHF101.61.
Key valuation signals for XSWX:ZBH:
Book Value per Share: CHF51.59
GF Value™: CHF101.61 vs. price of CHF73.50 (27.7% below fair value)
No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
72GF Score
Get the complete analysis for XSWX:ZBH
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ZBH has been successfully added to your 
